Dynavax Technologies Corporation (DVAX): Price and Financial Metrics
DVAX Price/Volume Stats
| Current price | $12.17 | 52-week high | $15.01 |
| Prev. close | $12.01 | 52-week low | $9.74 |
| Day low | $11.75 | Volume | 1,352,700 |
| Day high | $12.23 | Avg. volume | 2,170,304 |
| 50-day MA | $11.45 | Dividend yield | N/A |
| 200-day MA | $11.59 | Market Cap | 1.60B |
DVAX Stock Price Chart Interactive Chart >
Dynavax Technologies Corporation (DVAX) Company Bio
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, using TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. The company was founded in 1996 and is based in Berkeley, California.
DVAX Price Returns
| 1-mo | 10.74% |
| 3-mo | 5.92% |
| 6-mo | 6.85% |
| 1-year | -9.72% |
| 3-year | -25.15% |
| 5-year | 117.71% |
| YTD | -12.95% |
| 2023 | 31.39% |
| 2022 | -24.38% |
| 2021 | 216.18% |
| 2020 | -22.20% |
| 2019 | -37.49% |
Continue Researching DVAX
Want to see what other sources are saying about Dynavax Technologies Corp's financials and stock price? Try the links below:Dynavax Technologies Corp (DVAX) Stock Price | Nasdaq
Dynavax Technologies Corp (DVAX) Stock Quote, History and News - Yahoo Finance
Dynavax Technologies Corp (DVAX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...